
Following the t-cells procedure Luke was started back on
chemo. They tried to give him Erwinia
but he had an allergic reaction and they had to shut it down after a few
minutes and shoot him up with Benadryl.
Erwinia I’d describe as an indirect chemo. It breaks down a specific protein leukemia
cells are believed to need to grow and multiply. Without the protein the leukemia cells growth
is inhibited. After recovering from the
reaction to the Erwinia, Luke left the hospital around 9 PM.
Luke was back in clinic Wednesday morning. Luke met with Dr. August, the chemo doctor on
the trial team at CMH, and it was decided to let him get back to Houston and
make a decision in Houston on trying Erwinia again. Luke rested the rest of Wednesday and we headed
back to Houston on Thursday.
Friday he was at the MDA clinic and it was decided to try
Erwinia again. The results were the same
as KC. He had an allergic reaction. The Erwinia was stopped and he was shot up
with Benadryl. Luke was getting Erwinia
because he was also allergic to another Erwinia type drug. He had gotten Erwinia dozens of time before
without a problem, but it is not uncommon for someone to develop
hypersensitivity after multiple doses.
He’s back in MDA clinic Monday for Vincristine and its wait and see what
they want to do since he can’t tolerate Erwinia.
The overall plan from here is for Luke to get maintenance chemo
until his t-cells are ready to be reintroduced into his system. Novartis is the t-cell technology provider and
a date needs to be scheduled with them to process the t-cells. Dr. Myers next time slot for Novartis was mid-April. Processing takes three weeks so once the
cells go to Novartis Luke will likely be schedule a return to KC and receive
the t-cells the first week of May. It’s
expected he will be in KC for a month for t-cell reintroduction.
Just an overview of the clinical trial. They will extract Luke’s t-cells and genetically
modify them to introduce a receptor on the surface of the t-cell, That receptor will attach to a C19 protein that
is on the surface of the leukemia cells.
Attaching to the leukemia cell it is hoped that the t-cell kills the
leukemia cell.

No comments:
Post a Comment